drugset / Trial / NCT06608342
Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia
Phase 2
Recruiting
20 enrolled
Institute of Hematology & Blood Diseases Hospital, China
Juventas Cell Therapy Ltd. · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To observe the efficacy and side effects of autologous hematopoietic stem cell transplantation combined with CD19-CART for adult acute lymphoblastic leukemia, and to evaluate the safety and efficacy of this regimen in the treatment of acute lymphoblastic leukemia.
Timeline
- Start
- 2024-06-25
- Primary completion
- 2026-05-30
- Completion
- 2028-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD19 CAR-T cells | Cell therapy | — | — |